Mayne Pharma | MYX - Saham

Keuangan

AUD

AUD 1.14B

AUD 110.07M

Biaya Penjualan

AUD 43.74M

AUD 460.59M

Kewajiban Lancar

AUD 313.94M

AUD 38.82M

AUD -16.2M

AUD 20.9M

450

Eps Laba Per Saham

AUD -0.15

Modal Dan Cadangan

AUD 454.19M

Laba Kotor Pada Penjualan

AUD 86.13M

Beban Bunga Utang

AUD 1.2M

AUD 2.66M

Kapitalisasi Pasar

AUD 230.55M

Batas Pemasukan

AUD -103.68M

Biaya Operasional

AUD 103.54M

Laba Operasional

AUD -3.3M

Modal Saham Biasa

AUD 81.25M

Laba Sebelum Pajak

AUD -14.7M

Pendapatan Penjualan

AUD 212.07M

Beban Penjualan Dan Administrasi

AUD 54.8M

AUD 74.63M

Kreditur Perdagangan

AUD 30.25M

Debitur Perdagangan

AUD 193.22M

	Saham	Perubahan		Tanggal
Ansell	USD 584.7M		126.8M	2025-06
Avita Medical	AUD 6.93M		614K	2025-12
Cochlear	AUD 499.4M		107.8M	2025-06
CSL	USD 6.47B		327M	2025-06
Healius	AUD 31.9M		1.6M	2024-06
Integral Diagnostics	AUD 1.85M		2K	2023-12
Medical Developments International	AUD 9.45M		679K	2025-06
Nanosonics	AUD 18.63M		1.61M	2025-06
Polynovo	AUD 8.97M		2.08M	2024-06
Ramsay Health Care	AUD 404.4M		25M	2025-06
ResMed	USD 911.88M		33.33M	2026-03
Sigma Healthcare	AUD 324.85M		25.65M	2023-01
Sonic Healthcare	AUD 208.83M		3.83M	2024-06
Telix Pharmaceuticals	AUD 35.23M		2.91M	2025-06